Marion McCourt - EVP Commercial at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Commercial
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Marion McCourt - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Marion McCourt for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 12,931 $13.5 M $1,047.11 Jul 1, 2024 Direct
Common Stock 174 $182 K $1,047.11 Jul 1, 2024 By 401(k) Plan
Non-Qualified Stock Option (right to buy) 1,137 Jul 1, 2024 Direct Common Stock

Transactions reported by Marion McCourt for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership